➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
AstraZeneca
Boehringer Ingelheim
McKesson
Colorcon

Last Updated: November 24, 2020

DrugPatentWatch Database Preview

Litigation for NALTREXONE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

US Court Litigation for NALTREXONE

Patent Case Name Docket Date Filed Date Terminated Cause Court Jury Demand Link To Docket
6,264,987   Start Trial   Start Trial 2015-05-13 Court of Appeals for the Federal Circuit   Start Trial
6,264,987   Start Trial   Start Trial 2020-09-09 28:1338 Patent Infringement District Court, D. New Jersey None   Start Trial
6,667,061 Alkermes Pharma Ireland Limited v. Luye Pharma Group Ltd.   Start Trial 2019-07-17 2019-12-03 35:271 Patent Infringement District Court, D. Delaware None   Start Trial
>Patent >Case Name >Docket >Date Filed >Date Terminated >Cause >Court >Jury Demand >Link To Docket

Patent Trial and Appeal Board Cases for NALTREXONE

Patent Petitioner Status Filing Date Accorded Filing Date Patent Owner Trial Type Trial Number Decision Date Inventor Document Download
6,667,061 Luye Pharma Group Ltd.   Start Trial 2016-05-31 05-31-2016 Alkermes Controlled Therapeutics, Inc. Inter partes review   Start Trial 11-30-2016 J. Ramstack   Start Trial
6,667,061 Luye Pharma Group Ltd.   Start Trial 2016-05-31 05-31-2016 Ramstack et al Inter partes review   Start Trial 11-30-2016 J. Ramstack   Start Trial
7,919,499 Amneal Pharmaceuticals LLC   Start Trial 2018-04-20 05-09-2018 Ehrich, Elliot Inter partes review   Start Trial 11-07-2018   Start Trial
>Patent >Petitioner >Status >Filing Date >Accorded Filing Date >Patent Owner >Trial Type >Trial Number >Decision Date >Inventor >Document Download

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Express Scripts
Merck
Harvard Business School
Colorcon
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.